Answers are grounded in this paper and cite their sources.
Case reports highlight phenotypic variations in visceral myopathy linked to actg2 mutations, suggesting second-site impacts.
Background:ACTG2 (smooth muscle actin γ-2) is a gene associated with smooth muscle function. Introduction: Variants in this gene can lead to visceral myopathy (VM), which is a spectrum of various disorders affecting smooth muscle in different parts of the body. There is gap in the literature regarding understanding the full scope of ACTG2-related VM. Patients and methods: Here we present the clinical and molecular investigation of three patients with visceral smooth muscle diseases carrying pathogenetic variants in the ACTG2 gene. Discussion and conclusion: The severity of the disease varies in great extent, even among monochorionic twins sharing same mutation and intrauterine environment, suggesting that second-site factors are likely to impact disease manifestations.
No takes yet. Share an insight, caveat, or question.
Süüden et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: